CareLit · DOI-Nachweis · Aktuelle Neurologie
Integration of metabolic imaging and molecular genetic profiling of serial stereotactic biopsies are valuable for histological discrimination of oligodendrogliomas, mixed oligoastrocytomas and astrocytomas WHO° II/III
DOI 10.1055/s-0028-1086514
Bibliografische Angaben
Nachweis in CareLit
Autor:innenN Thon, C Erös, G Pöpperl, J Herms, J.C Tonn, F Kreth
ZeitschriftAktuelle Neurologie
Ausgabe09/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Modern treatment strategies of gliomas have to consider metabolic imaging and molecular markers with respect to individualized multimodal therapeutic regimes. Aim of this study was to correlate 18F-FET-PET based tumor grading, LOH1p/19q and MGMT promoter methylation with histological classification of gliomas WHO° II/III from serial stereotatic biopsies in patients with eloquently located tumors. Metho…
Zitieren
Zitierempfehlung
N Thon, C Erös, G Pöpperl, J Herms, J.C Tonn, F Kreth (2008) Integration of metabolic imaging and molecular genetic profiling of serial stereotactic biopsies are valuable for histological discrimination of oligodendrogliomas, mixed oligoastrocytomas and astrocytomas WHO° II/III. Aktuelle Neurologie (09). https://doi.org/10.1055/s-0028-1086514
Mit CareLit weiterarbeiten